Given the significant prevalence of onychomycosis that podiatrists see in practice, these authors review current treatments and offer a closer look at emerging topicals, orals and devices that may hold promise in treating this disease.

   Since the drug companies’ fungal wars of the 1990s, many podiatrists have lost interest in the treatment of onychomycosis and have settled into their own particular treatment paradigm. However, emerging technologies and new drug delivery systems have again brought the treatment of onychomycosis to the forefront of our profession.

Given the common prevalence and debilitating effects of neuropathic pain, it is important to have a strong understanding of effective treatment options. Accordingly, this author reviews the literature on currently available modalities as well as emerging therapies.

New Federal Rules Address Patient Record Breaches

By Brian McCurdy, Senior Editor

   Podiatry practices already spend a great deal of administrative time complying with the rules of the Health Insurance Portability and Accountability Act (HIPAA). However, practices will now need to adjust to new patient privacy provisions that ensure no personal health records are breached.

   These expert panelists expound on the use of orthotic treatment for a range of issues including hyperpronation, overuse injuries and posterior tibial tendon dysfunction. They also discuss treating pediatric patients with both flexible flatfoot and those with non-compensating equinus.

   Q: What are your insights into the orthotic treatment of pediatric flexible flatfoot following reconstructive surgery?

   What if there were one prescription that could prevent and help treat dozens of diseases such as diabetes, hypertension and obesity? Exercise is that prescription and physicians and healthcare providers need to prescribe it to patients who are not exercising regularly.